Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bas Karels"'
Autor:
Amber Blaauboer, Stephanie Booy, Peter M. van Koetsveld, Bas Karels, Fadime Dogan, Suzanne van Zwienen, Casper H. J. van Eijck, Leo J. Hofland
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Adjuvant gemcitabine for pancreatic cancer has limited efficacy in the clinical setting. Impaired drug metabolism is associated with treatment resistance. We aimed to evaluate the chemosensitising effect of interferon-beta (IFN-β
Externí odkaz:
https://doaj.org/article/d7528e192b7149b28bd793a959ebfbe7
Autor:
Karina Prins, Martin Huisman, Anke McLuskey, Rosinda Mies, Bas Karels, Patric J. D. Delhanty, Jenny A. Visser
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism, 322(6), E494-E507. American Physiological Society
Binge-eating disorder is the most prevalent eating disorder diagnosed, affecting three times more women than men. Ghrelin stimulates appetite and reward signaling, and loss of its receptor reduces binge-eating behavior in male mice. Here, we examined
Autor:
Bas Karels, Amber Blaauboer, Casper H.J. van Eijck, Suzanne van Zwienen, Stephanie Booy, Fadime Dogan, Peter M. van Koetsveld, Leo J. Hofland
Publikováno v:
BMC Cancer
BMC Cancer, 20(1):913. BioMed Central Ltd.
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Cancer, 20(1):913. BioMed Central Ltd.
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Background Adjuvant gemcitabine for pancreatic cancer has limited efficacy in the clinical setting. Impaired drug metabolism is associated with treatment resistance. We aimed to evaluate the chemosensitising effect of interferon-beta (IFN-β). Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c34c37deae3142c65fd2f1f4f2f8a1
https://doi.org/10.21203/rs.3.rs-39801/v3
https://doi.org/10.21203/rs.3.rs-39801/v3
Autor:
Casper H.J. van Eijck, Leo J. Hofland, Peter M. van Koetsveld, Bas Karels, Stephanie Booy, Suzanne vanZwienen, Fadime Dogan, Amber Blaauboer
Publikováno v:
Advances in Cancer Research & Clinical Imaging. 2
Autor:
Jeffrey Hoek, Bas Karels, Axel Pn Themmen, Jenny A Visser, Anke McLuskey, Piet Kramer, Houten E Leonie A F van
Publikováno v:
Endocrine Abstracts.
Autor:
Ursula M. Rose, Jan Th. J. Uilenbroek, J. Anton Grootegoed, Bas Karels, Maria J. G. Gruijters, Alexandra L. L. Durlinger, Frank H. de Jong, Piet Kramer, Martin M. Matzuk, Axel P. N. Themmen, T. Rajendra Kumar
Publikováno v:
Endocrinology. 142:4891-4899
Although ovarian follicle growth is under the influence of many growth factors and hormones of which FSH remains one of the most prominent regulators. Therefore, factors affecting the sensitivity of ovarian follicles to FSH are also important for fol
Autor:
Piet Kramer, J. Anton Grootegoed, Bas Karels, Alexandra L. L. Durlinger, Frank H. de Jong, Axel P. N. Themmen, Jan Th. J. Uilenbroek
Publikováno v:
Endocrinology. 140:5789-5796
The dimeric glycoprotein anti-Mullerian hormone (AMH) is a mem- ber of the transforming growth factor-b superfamily of growth and differentiation factors. During male fetal sex differentiation, AMH is produced by Sertoli cells and induces degeneratio
Autor:
R de Leeuw, Piet Kramer, J. Th. J. Uilenbroek, E. C. M. van Leeuwen, Bas Karels, F. H. De Jong, M A Timmerman
Publikováno v:
Journal of Endocrinology. 150:85-92
To investigate whether the progesterone antagonist RU486 has a direct effect on ovarian function, it was administered to immature female rats rendered hypogonadotrophic by administration of an LHRH antagonist and in which follicle development was sti
Autor:
Jenny A. Visser, Bas Karels, Anke McLuskey, E. Leonie A.F. van Houten, Piet Kramer, Axel P. N. Themmen
Publikováno v:
Endocrinology, 153, 2861-2869. Endocrine Society
Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women in their reproductive age, is characterized by both reproductive and metabolic features. Recent studies in human, nonhuman primates, and sheep suggest that hyperandrogenism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6f84c57bf643c7ffa0cf460a0f9ab2
https://pure.eur.nl/en/publications/d482f4db-79d2-46c6-a7ab-3d53db3bb0d9
https://pure.eur.nl/en/publications/d482f4db-79d2-46c6-a7ab-3d53db3bb0d9
Publikováno v:
Life Sciences. 50:1173-1178
To determine if the antiprogestagen RU486 has a direct effect on luteal progesterone secretion, whole corpora lutea or dispersed luteal cells were incubated in the presence of RU486. Whole corpora lutea, isolated from rats at day 5 of pseudopregnancy